Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.

Active substance factsheet - Last updated: 30/01/2023

Active substance

Substance name:

(RS)-α-cyano-3phenoxybenzyl-(1RS)-cis, trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate (Cypermethrin)

EC number:

-; 257-842-9

CAS number:

52315-07-8

IUPAC name:

α-cyano-3-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate

BAS number:

1283

Product-type:

PT18

Candidate for substitution:

No

Regulatory categorisation:

Review programme substance

Approval/Assessment status:

Approved - Other updates in progress
-

Harmonised classification and labeling of the substance

C&L inventory

Related authorised biocidal products

6 related products

Trade name
Market area
Autorisation Type

-

Mirmex GR

Greece

Spain

 National authorisation Link to the factsheet

CIPER DP

Greece

 National authorisation Link to the factsheet

Dk one

Greece

 National authorisation Link to the factsheet

Draker One

Greece

 National authorisation Link to the factsheet

DURACID PW rovarirtó porozószer

Duracid PW

Greece

Hungary

 National authorisation Link to the factsheet

FREE LAND DUST

Greece

 National authorisation Link to the factsheet
Approval data details
Administrative identifiers

Evaluating competent authority:

Belgium

R4BP asset number:

EU-0017395-0000

Approval identifiers

Legal act:

Reg(EU) 2018/1130

Validity of approval

Start date:

01/06/2020

End date:

31/05/2030

Documents
Assessment Reports

Assessment Report

Cypermethrin_PT18_Appendix_III_Reference_list.pdf (en)

Cypermethrin_PT18_docIIB.pdf (en)

Cypermethrin_PT18_docIIC.pdf (en)

Cypermethrin_PT18_docIIA.pdf (en)

Cypermethrin_PT18_docI_Final_Version_Redacted.pdf (en)

Study summaries (Document III-A)

Study summary

DocIIIA.zip (en)

Other documents

BPC opinions

Cypermethrin_PT 18_Final BPC opinion.pdf (en)

Update of scientific data of active substance
Assessment information

Evaluating competent authority:

Belgium

Assessment outcome:

In progress

Conclusion date:

Validity of approval

Start date:

End date:

Legal act:

Documents
Assessment Reports
Study summaries (Document III-A)
Other documents
Amendment of active substance - Conclusion Date: 21/05/2019   This item is not a consequence of further evaluation of the substance
Assessment information

Evaluating competent authority:

-

Assessment outcome:

Successful

Conclusion date:

21/05/2019

Validity of approval

Start date:

01/06/2020

End date:

31/05/2030

Legal act:

Reg(EU) 2018/1130

Documents
Assessment Reports

Assessment Report

Cypermethrin_PT18_Appendix_III_Reference_list.pdf (en)

Cypermethrin_PT18_docIIB.pdf (en)

Cypermethrin_PT18_docIIC.pdf (en)

Cypermethrin_PT18_docIIA.pdf (en)

Cypermethrin_PT18_docI_Final_Version_Redacted.pdf (en)

Study summaries (Document III-A)

Study summary

DocIIIA.zip (en)

Other documents

BPC opinions

Cypermethrin_PT 18_Final BPC opinion.pdf (en)

Amendment of active substance - Conclusion Date: 18/02/2019   This item is not a consequence of further evaluation of the substance
Assessment information

Evaluating competent authority:

-

Assessment outcome:

Successful

Conclusion date:

18/02/2019

Validity of approval

Start date:

01/06/2020

End date:

31/05/2030

Legal act:

Reg(EU) 2018/1130

Documents
Assessment Reports
Study summaries (Document III-A)
Other documents

BPC opinions

Cypermethrin_PT 18_Final BPC opinion.pdf (en)

Approval of active substance - Conclusion Date: 04/09/2018  
Assessment information

Evaluating competent authority:

Belgium

Assessment outcome:

Successful

Conclusion date:

04/09/2018

Validity of approval

Start date:

01/06/2020

End date:

31/05/2030

Legal act:

Reg(EU) 2018/1130

Documents
Assessment Reports
Study summaries (Document III-A)
Other documents

BPC opinions

Cypermethrin_PT 18_Final BPC opinion.pdf (en)